HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Covid-19 Storm, Supplement Manufacturers' Safe Harbor Could Be Qualifying New Suppliers

Executive Summary

US manufacturers losing ingredient supplies from China may need to qualify more suppliers, potentially requiring tests of all lots, says EAS Consulting. Contract and other manufacturers also should identify alternative sources for materials they receive from China and prepare for shortages from other countries.

You may also be interested in...



Coronavirus Pandemic Disrupting Dietary Ingredient Supply Chain? USDA Wants To Know

'We've got be sure that companies can continue to get ingredients for their products," says CRN CEO Steve Mister, Concern supplies from India, which is a week into a a three-week nationwide lockdown, and other potential supply chain problems were noted by CRN members in a survey it conducted to help USDA gauge global food and nutrition ingredient supply chains during the pandemic.

Supplement Firms Should Tighten Supply Gatekeeping As FDA Suspends Inspections

Supplement manufacturers should increase vigilance over supply chains after FDA suspends routine facility inspections and certain requirements of its foreign supplier verification program. Firms should verify even their trusted supplier’s next few certificates of analysis and step-up adverse event monitoring.

Pandemic Could Turn Supplement Firms To Drug Production, Helping Fill Public Health Gaps

The Covid-19 pandemic could push food and supplement manufacturers to switch to manufacturing OTC or Rx drugs to help fill public health gaps, says a former deputy director of FDA's Office of Dietary Supplement Programs. Many marketers are well equipped to make OTC drugs, he added in FDLI webinar.

Related Content

Topics

UsernamePublicRestriction

Register

LL1135490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel